Pain
Conference Coverage
When is preventive treatment of migraine appropriate?
STOWE, VT. – Preventive treatment of migraine can reduce disability and decrease the risk of transformation to...
Feature
Elderly Americans carry heavier opioid burden
Those over age 65 years fill prescriptions for twice the amount, compared with younger adults.
Literature Review
American Headache Society updates guideline on neuroimaging for migraine
In routine cases with no atypical features, neuroimaging for migraine is unnecessary.
Conference Coverage
Implantable stimulator shows promise for chronic knee pain
A small, five-patient case series shows pain intensity had dropped substantially 6 months after implantation.
FDA/CDC
FDA OKs first orally disintegrating agent for rapid migraine relief
This is the first CGRP receptor antagonist available in a fast-acting orally disintegrating tablet for the acute treatment of migraine in adults...
FDA/CDC
FDA approves first IV migraine prevention drug
“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine...
From the Journals
Tramadol use for noncancer pain linked with increased hip fracture risk
"Our results point to the need to consider tramadol's associated risk of fracture in clinical practice and treatment guidelines," the researchers...
From the Journals
Pharmacologic prophylaxis fails in pediatric migraine
A network meta-analysis of pharmacologic prophylaxis shows little evidence for efficacy in children.
Conference Coverage
Shift in approach is encouraged in assessing chronic pain
SAN DIEGO – “The time has come to move past using a one-size-fits-all approach to assess the fifth vital sign,” Dr. Bonakdar said.
Literature Review
Dependent trait in chronic migraine may predict nonresponse to onabotulinumtoxin A
The results of a case-control study may influence the management and outcome of patients with chronic migraine.
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010